The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Vera Therapeutics Inc (NASDAQ: VERA) closed at $24.0 in the last session, up 1.48% from day before closing price of $23.65. In other words, the price has increased by $1.48 from its previous closing price. On the day, 0.63 million shares were traded. VERA stock price reached its highest trading level at $24.26 during the session, while it also had its lowest trading level at $23.44.
Ratios:
We take a closer look at VERA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 27.30 and its Current Ratio is at 27.30. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $49.
On January 28, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $58.Goldman initiated its Buy rating on January 28, 2025, with a $58 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when ENRIGHT PATRICK G bought 209,393 shares for $20.87 per share. The transaction valued at 4,369,676 led to the insider holds 3,569,522 shares of the business.
ENRIGHT PATRICK G bought 40,607 shares of VERA for $907,635 on Jun 24 ’25. The Director now owns 3,596,593 shares after completing the transaction at $22.35 per share. On Feb 21 ’25, another insider, Fordyce Marshall, who serves as the PRESIDENT AND CEO of the company, sold 10,613 shares for $27.89 each. As a result, the insider received 296,032 and left with 213,740 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1530580736 and an Enterprise Value of 967150144.
Stock Price History:
The Beta on a monthly basis for VERA is 1.19, which has changed by -0.33296275 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is 5.09%, while the 200-Day Moving Average is calculated to be -28.37%.
Shares Statistics:
According to the various share statistics, VERA traded on average about 1.81M shares per day over the past 3-months and 1613920 shares per day over the past 10 days. A total of 63.77M shares are outstanding, with a floating share count of 45.63M. Insiders hold about 28.45% of the company’s shares, while institutions hold 90.09% stake in the company. Shares short for VERA as of 1749772800 were 9560166 with a Short Ratio of 5.29, compared to 1747267200 on 7069204. Therefore, it implies a Short% of Shares Outstanding of 9560166 and a Short% of Float of 17.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
